Lip Augmentation Market Size to Hit USD 15.96 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Lip Augmentation Market

5.1. COVID-19 Landscape: Lip Augmentation Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Lip Augmentation Market, By Product Type

8.1. Lip Augmentation Market Revenue and Volume Forecast, by Product Type

8.1.1. Dermal Fillers

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Lip Implants

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Lip Plumpers

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Others

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Lip Augmentation Market, By Procedure Type

9.1. Lip Augmentation Market Revenue and Volume Forecast, by Procedure Type

9.1.1. Non-surgical Lip Augmentation

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Surgical Lip Augmentation

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Lip Augmentation Market, By End-User

10.1. Lip Augmentation Market Revenue and Volume Forecast, by End-User

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Clinics & Dermatology Centers

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Medical Spas

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Others (Plastic Surgery Centers, Aesthetic Clinics)

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Lip Augmentation Market, By Application

11.1. Lip Augmentation Market Revenue and Volume Forecast, by Application

11.1.1. Cosmetic

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Reconstructive (Post-trauma or congenital defect correction)

11.1.2.1. Market Revenue and Volume Forecast

Chapter 12. Global Lip Augmentation Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type

12.1.2. Market Revenue and Volume Forecast, by Procedure Type

12.1.3. Market Revenue and Volume Forecast, by End-User

12.1.4. Market Revenue and Volume Forecast, by Application

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type

12.1.5.2. Market Revenue and Volume Forecast, by Procedure Type

12.1.5.3. Market Revenue and Volume Forecast, by End-User

12.1.5.4. Market Revenue and Volume Forecast, by Application

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type

12.1.6.2. Market Revenue and Volume Forecast, by Procedure Type

12.1.6.3. Market Revenue and Volume Forecast, by End-User

12.1.6.4. Market Revenue and Volume Forecast, by Application

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type

12.2.2. Market Revenue and Volume Forecast, by Procedure Type

12.2.3. Market Revenue and Volume Forecast, by End-User

12.2.4. Market Revenue and Volume Forecast, by Application

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type

12.2.5.2. Market Revenue and Volume Forecast, by Procedure Type

12.2.5.3. Market Revenue and Volume Forecast, by End-User

12.2.5.4. Market Revenue and Volume Forecast, by Application

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type

12.2.6.2. Market Revenue and Volume Forecast, by Procedure Type

12.2.6.3. Market Revenue and Volume Forecast, by End-User

12.2.6.4. Market Revenue and Volume Forecast, by Application

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type

12.2.7.2. Market Revenue and Volume Forecast, by Procedure Type

12.2.7.3. Market Revenue and Volume Forecast, by End-User

12.2.7.4. Market Revenue and Volume Forecast, by Application

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type

12.2.8.2. Market Revenue and Volume Forecast, by Procedure Type

12.2.8.3. Market Revenue and Volume Forecast, by End-User

12.2.8.4. Market Revenue and Volume Forecast, by Application

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type

12.3.2. Market Revenue and Volume Forecast, by Procedure Type

12.3.3. Market Revenue and Volume Forecast, by End-User

12.3.4. Market Revenue and Volume Forecast, by Application

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type

12.3.5.2. Market Revenue and Volume Forecast, by Procedure Type

12.3.5.3. Market Revenue and Volume Forecast, by End-User

12.3.5.4. Market Revenue and Volume Forecast, by Application

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type

12.3.6.2. Market Revenue and Volume Forecast, by Procedure Type

12.3.6.3. Market Revenue and Volume Forecast, by End-User

12.3.6.4. Market Revenue and Volume Forecast, by Application

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type

12.3.7.2. Market Revenue and Volume Forecast, by Procedure Type

12.3.7.3. Market Revenue and Volume Forecast, by End-User

12.3.7.4. Market Revenue and Volume Forecast, by Application

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type

12.3.8.2. Market Revenue and Volume Forecast, by Procedure Type

12.3.8.3. Market Revenue and Volume Forecast, by End-User

12.3.8.4. Market Revenue and Volume Forecast, by Application

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type

12.4.2. Market Revenue and Volume Forecast, by Procedure Type

12.4.3. Market Revenue and Volume Forecast, by End-User

12.4.4. Market Revenue and Volume Forecast, by Application

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type

12.4.5.2. Market Revenue and Volume Forecast, by Procedure Type

12.4.5.3. Market Revenue and Volume Forecast, by End-User

12.4.5.4. Market Revenue and Volume Forecast, by Application

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type

12.4.6.2. Market Revenue and Volume Forecast, by Procedure Type

12.4.6.3. Market Revenue and Volume Forecast, by End-User

12.4.6.4. Market Revenue and Volume Forecast, by Application

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type

12.4.7.2. Market Revenue and Volume Forecast, by Procedure Type

12.4.7.3. Market Revenue and Volume Forecast, by End-User

12.4.7.4. Market Revenue and Volume Forecast, by Application

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type

12.4.8.2. Market Revenue and Volume Forecast, by Procedure Type

12.4.8.3. Market Revenue and Volume Forecast, by End-User

12.4.8.4. Market Revenue and Volume Forecast, by Application

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.2. Market Revenue and Volume Forecast, by Procedure Type

12.5.3. Market Revenue and Volume Forecast, by End-User

12.5.4. Market Revenue and Volume Forecast, by Application

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.5.2. Market Revenue and Volume Forecast, by Procedure Type

12.5.5.3. Market Revenue and Volume Forecast, by End-User

12.5.5.4. Market Revenue and Volume Forecast, by Application

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type

12.5.6.2. Market Revenue and Volume Forecast, by Procedure Type

12.5.6.3. Market Revenue and Volume Forecast, by End-User

12.5.6.4. Market Revenue and Volume Forecast, by Application

Chapter 13. Company Profiles

13.1. Allergan (AbbVie)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerProduct Typeance

13.1.4. Recent Initiatives

13.2. Ipsen

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerProduct Typeance

13.2.4. Recent Initiatives

13.3. Sinclair Pharma

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerProduct Typeance

13.3.4. Recent Initiatives

13.4. Hugel, Inc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerProduct Typeance

13.4.4. Recent Initiatives

13.5. Mentor Worldwide LLC (Johnson & Johnson)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerProduct Typeance

13.5.4. Recent Initiatives

13.6. LG Chem

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerProduct Typeance

13.6.4. Recent Initiatives

13.7. SINOCARE Lifescience Co., Ltd.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerProduct Typeance

13.7.4. Recent Initiatives

13.8. Revance Therapeutics, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerProduct Typeance

13.8.4. Recent Initiatives

13.9. Ipsen Pharma

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerProduct Typeance

13.9.4. Recent Initiatives

13.10. BioScience Laboratories

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerProduct Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The lip augmentation market size is expected to increase from USD 7.50 billion in 2024 to USD 15.96 billion by 2034.

The lip augmentation market is expected to grow at a compound annual growth rate (CAGR) of around 7.84% from 2025 to 2034.

The major players in the lip augmentation market include Allergan (AbbVie), Ipsen, Sinclair Pharma, Hugel, Inc, Mentor Worldwide LLC (Johnson & Johnson), LG Chem, SINOCARE Lifescience Co., Ltd., Revance Therapeutics, Inc., Ipsen Pharma, BioScience Laboratories, Hansbiomed Co., Ltd., Medytox, Inc., Anteis S.A., Sinclair Pharma (acquired by Ipsen), Teoxane Laboratories, Croma-Pharma GmbH, LG Life Sciences, Regen Lab SA, Matex La, Prollenium Medical Technologies Inc., and Sun. Pharma.

The driving factors of the lip augmentation market are the evolving beauty standards and advancements in cosmetic procedures. As more individuals seek to enhance their facial aesthetics, the demand for lip augmentation treatments continues to rise.

North America region will lead the global lip augmentation market during the forecast period 2025 to 2034.